Disclosures Dr Oppenheimer is a consultant for AstraZeneca, Amgen, Aimmune, ARS, Aquestive, and GlaxoSmithKline; serves in adjudication/Data and Safety Monitoring Boards for Novartis, GlaxoSmithKline, AstraZeneca, Regeneron/Sanofi, and Amgen; is a reviewer for UpToDate; and is an editor for Medscape and executive editor for the Annals of Allergy, Asthma & Immunology. Dr Mustafa is on the speakers bureau of Genentech, GlaxoSmithKline, AstraZeneca, and Regeneron/Sanofi; receives grant from Takeda. Dr Shaker is a member and co-chair of the Joint Task Force on Practice Parameters; serves on the editorial board of The Journal of Allergy and Clinical Immunology In Practice; is an associate editor of Annals of Allergy, Asthma & Immunology; serves on the board of directors of the American Academy of Allergy, Asthma, and Immunology (views expressed are his own); and has participated in research that has received funding from DBV. The remaining authors have no conflicts of interest to report.